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A B S T R A C T   
Objective: Despite the prevalence of depression in women with gestational diabetes mellitus (GDM) and the 
relationship between mental health (depression and well-being) and metabolic health, little is known about 
mental health or its metabolic impact in GDM pregnancy. This prospective clinical cohort study aimed to 
investigate associations between 1) well-being and depression, and 2) mental health and weight/weight gain in 
women with GDM. 
Methods: We included 334 pregnant women with GDM treated at a Swiss University Hospital between January 
2016 and December 2018. They completed two self-report questionnaires: The World Health Organization well- 
being index (WHO-5) at the first (29 weeks of gestation) and last (36 weeks of gestation) GDM visits during 
pregnancy and the Edinburgh Postnatal Depression Scale (EPDS) at the first GDM visit. A cut-off of ≥11 was 
selected for this questionnaire to indicate the presence of elevated depression scores. 
Results: There was an inverse association between the well-being and depression total scores at the first GDM visit 
during pregnancy (r = − 0.55; p < 0.0001). Elevated depression scores at the first GDM visit were associated with 
subsequent weight gain in GDM pregnancy (β = 1.249; p = 0.019). 
Conclusion: In women with GDM, elevated depression scores during pregnancy are prospectively associated with 
weight gain. Depression symptoms should therefore be screened for and treated in women with GDM to reduce 
the risks associated with excessive weight gain during pregnancy.   
1. Introduction 
Gestational diabetes mellitus (GDM) can increase the burden of 
pregnancy as women are confronted to an increased risk of adverse 
maternal and neonatal outcomes and are asked to undergo several 
lifestyle changes to reduce these risks [1]. Depression in early pregnancy 
increases the risk of GDM [2] and women with GDM have up to a three- 
fold higher risk of developing depression during pregnancy compared to 
women without GDM [2–6]. Depression during pregnancy, and espe-
cially in women with GDM, is associated with important adverse 
outcomes in the mother (higher rates of preeclampsia and hypertension) 
and the child (low birth weight, preterm delivery and higher risk of 
instrumental delivery) [7–12]. Some of the adverse effects associated 
with depression in pregnancy could be due to epigenetic modifications 
[13]. Firstly, some women have a genetic predisposition for depression 
in pregnancy [14]. Secondly, preceding adverse or stressful events in 
pregnancy may lead to epigenetic modifications of genes that regulate 
inflammatory pathways, increase levels of proinflammatory cytokines, 
and lower levels of oxytocin, all of which may increase maternal 
depressive symptoms and, in turn, be associated with adverse outcomes 
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in the offspring [15]. After pregnancy, depression is associated with 
difficulties in breastfeeding [16] and poor attachment with the child 
[17]. Even though previous literature demonstrates there is a comor-
bidity between high BMI and depression in the general pregnant popu-
lation [18] and that both of these elements have an impact on the risk of 
developing GDM [2] depression is still understudied in women with 
GDM, particularly with regards to its association with metabolic health, 
such as weight [19]. 
Another important mental health variable to consider in women with 
GDM is well-being. Well-being, more precisely, emotional well-being as 
measured by the World Health Organization – Five Well-Being Index 
(WHO-5) [20], can be described as “the emotional quality of an in-
dividual’s everyday experience—the frequency and intensity of experi-
ences of joy, stress, sadness, anger, and affection that make one’s life 
pleasant or unpleasant” [21]. Similarly to higher symptoms of depres-
sion, well-being could also be lower in women with GDM than in the 
general pregnant population. As the prevalence of obesity is higher in 
women with GDM, lower well-being could result from frustrations 
related to obesity and potentially to multiple attempts to control weight 
[1,22]. On the other hand, well-being is associated with improved dia-
betes self-management, lifestyle behavior, and health outcomes in 
populations with diabetes, [23]. Therefore, if women with GDM have 
poorer well-being, this could lead to a poorer management of their 
diabetes, unhealthy lifestyle behaviours, and in turn, may impact their 
metabolic outcomes. Thus, we believe it is necessary to investigate this 
variable in women with GDM, as, to our knowledge, well-being has not 
been studied in this population. Investigating well-being may lead to a 
broader understanding of the potential impacts of mental health on 
metabolic outcomes, such as weight or weight gain. In order to under-
stand mental health in a comprehensive way, we chose to investigate 
both depression and well-being in women with GDM. This would enable 
us to use the WHO-5 scale as another measure of depression symptoms, 
as proposed in other populations outside pregnancy [20,24–26]. 
In the general pregnant population, mental health (depression and 
lower well-being) has been shown to be inversely associated with weight 
or weight gain. Indeed, in some studies, antepartum depression is 
associated with weight gain during pregnancy [27–29]. Furthermore, 
pregnant women experiencing depression and stress are more likely to 
consume energy-dense, nutrient-poor foods, thus decreasing their di-
etary quality and increasing their risk for excessive gestational weight 
gain and subsequent obesity [30]. Well-being, in the general pregnant 
population, and at five years postpartum has been associated with less 
weight retention [31]. Thus, well-being may be related to health be-
haviours that impact on weight in women with GDM. Women with GDM 
have a higher risk of increased weight gain than in the general pregnant 
population [22]. Weight gain can increase adverse outcomes, such as 
hypertensive disorders during pregnancy [32] and weight retention in 
the postpartum period may augment the risk of developing type 2 dia-
betes and cardiovascular disease later in life [33–36]. Excessive gesta-
tional weight gain in women with GDM may also lead to perinatal 
complications, including higher risk of preterm and caesarean delivery, 
macrosomia, and birth weight over the 90th percentile for age and sex 
[37–39]. Despite this, the association of mental health with weight has 
not been studied in women with GDM. 
This study aimed to investigate the associations between depression 
and well-being during GDM pregnancy to capture mental health in a 
broad manner and secondly, to investigate the associations between 
depression and well-being with weight and weight gain during GDM 
pregnancy. 
2. Materials and methods 
2.1. Setting 
This prospective clinical cohort study included pregnant women 
diagnosed with GDM after their first visit at the GDM clinic at a 
University Hospital in Switzerland. During the first GDM visit that takes 
place at around 29 weeks of gestation (Mean = 28.9 ± SD = 3.3), pa-
tients are generally seen by a clinical nurse specialist in GDM or a 
physician; they receive information on GDM, and are taught how to 
perform a capillary blood glucose test. Women are usually seen by a 
dietician one week later and then followed up by a nurse or a physician 
about once every two weeks. Women commonly attend their last GDM 
visit before giving birth at around 36 weeks of gestation (Mean = 36.2 ±
SD = 1.9). 
2.2. Participant consent and recruitment 
Women who were diagnosed with GDM according to the American 
Diabetes Association (ADA) guidelines and the International Association 
of the Diabetes and Pregnancy Study Groups (IADPSG) [34,40], were 
asked to take part in the GDM cohort by the research team and were 
given a consent form to sign containing further information on data 
usage. The Human Research Ethics Committee of the Canton de Vaud; 
our local ethics committee, approved the study protocol (study n◦ 326/ 
15). 
2.3. Inclusion and exclusion criteria 
Subjects were eligible if they had a GDM diagnosis, were followed up 
in our clinic between January 2016 (when we started to routinely collect 
mental health data) and December 2018, and gave written consent to 
participate. Therefore, 334 consecutive women were included in this 
study. 
2.4. Measures 
2.4.1. Maternal depression symptoms 
2.4.1.1. Edinburgh Postnatal Depression Scale (EPDS). This question-
naire, measuring symptoms of depression in the preceding seven days 
[41], was completed by participants during their first GDM visit. Each 
item is scored on a 4-point scale, the minimum and maximum scores 
being 0 and 30, respectively. The EPDS has been validated in pregnant 
women [42], as well as in a French sample of women in the postpartum 
period and the scale had good criterion validity and internal consistency 
(Cronbach’s alpha: 0.76) and good short term test-retest reliability 
(0.98) [43]. In this study, we used the EPDS score as a continuous var-
iable (depression total score) and we also created a dichotomous vari-
able with a cut-off of ≥11, as a score of ≥11 can indicate the presence of 
a major depressive disorder in pregnancy [42]. This cut-off was chosen 
based on the high sensitivity and specificity it has in detecting symptoms 
of depression [42,44,41]. It is also considered as an optimal threshold 
when compared to detection of depression through the DSM-5 and ICD- 
10 [45]. Nonetheless, as the gold standard for depression screening is 
clinical interviewing [46], we interpreted a score of ≥11 as “elevated 
depression score”. This questionnaire was given to the patients in French 
or English. In order to ensure that we were accounting for the multi- 
ethnicity and diversity of women coming to our clinic, a professional 
certified translator assisted women who did not speak French or English 
to complete this questionnaire. 
2.5. Maternal well-being index 
2.5.1. World Health Organization - Five Well-Being Index (WHO-5) 
This questionnaire was completed by participants during their first 
and last GDM visit. Well-being was measured with the WHO-5, which 
consists of 5 questions assessing the subjective well-being of the par-
ticipants [47]. The items are unidimensional and measure well-being by 
statements such as: “I have felt cheerful and in good spirits” on a 5-point 
Likert scale ranging from 0 ‘at no time’ to 5 ‘all of the time’. The final 
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score is then calculated by multiplying the score by 4, thus the final total 
score ranges from 0 to 100. The WHO-5 was originally designed to 
measure positive well-being (coping with illness), negative well-being 
(depression and anxiety) and energy. As the relationship between 
well-being and metabolic health in GDM pregnancy has not been studied 
so far, we chose to use this questionnaire to measure positive well-being 
[48]. The scale has adequate validity, has good psychometric properties 
in French as the Cronbach’s alpha is 0.88, confirming good internal 
consistency, it has been applied successfully across a wide range of study 
fields, though it has been used most extensively in endocrinology 
[47,49]. As the WHO-5 is validated in 31 different languages, we were 
able to distribute them to a variety of women from different ethnicities. 
2.6. Maternal anthropometric, obstetric and sociodemographic variables 
At the first GDM visit, women were weighed wearing light clothes 
and without shoes, and their height was measured. At the last GDM visit, 
their weight was measured again. The weight gain variable was thus 
calculated by subtracting the weight at the first GDM visit from the 
weight at the last GDM visit. Age, gestational age and educational level 
were assessed by interview or extracted from the patient’s medical re-
cord. Additionally, patients answered questions about their social sup-
port (lives with partner vs lives alone) during the first GDM visit. 
2.7. Data analysis 
All analyses were carried out with Stata/SE 15.0 (StataCorp LLC, TX, 
USA). Descriptive statistics were carried out for socio-demographic 
variables (please refer to Table 1). Ordinal outcomes were described 
as frequencies and percentages. For continuous variables, normality of 
distribution was graphically assessed with normal QQ-plots. Those 
variables were then described with their mean and standard deviation. 
Univariate linear regressions analyses were conducted for all aims 
(Model 1) in order to evaluate the raw associations between two vari-
ables of interest. These associations were then adjusted for confounding 
variables (Model 2, see below). 
For the first aim, a paired t-test was conducted to study if well-being 
changed between the first GDM visit and the end of pregnancy (i.e., last 
GDM visit). Then, as our first aim was to investigate the association 
between well-being and depression total scores, we performed a linear 
regression where the independent variables were the depression total 
score and cut-off of ≥11 (i.e., elevated depression score) at the first GDM 
visit and the dependent variable was the well-being total score at the 
first GDM visit. For the second aim investigating the associations be-
tween mental health variables (depression and well-being) and weight 
(gain), linear regressions were performed. The independent variables 
were the depression total score and the cut-off of ≥11 and the well-being 
total score, all at the first GDM visit; the dependent variables were 
weight at the first GDM visit and weight gain between the first and last 
GDM visit. 
In model 1, no adjustments for confounding factors were made. In 
model 2, adjustments for the following confounding variables were 
made for all linear regressions: maternal age, gestational age, educa-
tional level, and social support at the first GDM visit. For the first aim, 
we also added BMI (Body Mass Index) at the first GDM visit as a 
confounder. For the second aim, we only added BMI as a confounder 
when the dependent variable was weight gain. Gestational age was 
added as a confounder, as it can have an impact on the mother’s weight 
[50]. Maternal educational level [51] and social support status [52] 
were added as confounders, as they have an impact on the mother’s 
mental health. 
At the first GDM visit, there were seven missing cases for height, 18 
missing cases for weight, 19 missing cases for BMI, 53 missing cases for 
weight gain, two missing cases for gestational age, five missing cases for 
ethnicity of the patients, 25 missing cases for social support, 57 missing 
cases for educational level, 42 missing cases for the depression total 
score and cut-off ≥11, 39 missing cases for the well-being total score. At 
the last GDM visit, there were 120 missing cases for gestational age and 
105 missing cases for the well-being total score. Based on the Missing at 
Random assumption, we conducted imputations by using the Multiple 
Imputation by Chained Equations method [53]. This led to similar re-
sults (data not shown; available upon request); thus, we chose to use the 
original data for the present analysis. 
2.8. Data sharing statement 
Data is available from the first author upon request. 
3. Results 
3.1. Sample characteristics 
Sample characteristics are described in Table 1. At the first GDM 
visit, participants had a mean age of 33.4 ± 5.5 years, a mean gestational 
age of 28.9 ± 3.3 weeks, a mean weight of 78.3 ± 14.8 kg, a mean well- 
being total score of 60.1 ± 20.2 and a mean depression total score of 7.5 
± 5.5, with 26.0% of women having an elevated depression score. At the 
last GDM visit, the mean gestational age was 36.2 ± 1.9 weeks, the mean 
weight was 80.6 ± 14.8 kg and the mean well-being total score 67.2 ±
18.3. 
3.2. Changes and associations between mental health variables during 
pregnancy 
The well-being total score increased from 60.3 ± 20.5 at the first 
GDM visit to 67.4 ± 17.9 at the last GDM visit, indicating a 7.1 point (±
16.5) or an 11.8% increase on average in the in well-being total score 
among study participants (CI = 4.9–9.3; p < 0.0001). An inverse strong 
association between the well-being total score and the depression total 
score (β = − 2.08; r = − 0.55; p < 0.0001) and an inverse moderate 
Table 1 
Sample characteristics: Maternal sociodemographic, anthropometric, obstetric, 
and mental health variables.   
Mean (SD) n (%) 
Maternal sociodemographic and anthropometric 
variables   
Age (years) 33.4 (5.5)  
Educational level   
Compulsory education not completed  20 (7.2%) 
Compulsory education completed  58 (20.9%) 
Secondary school  40 (14.4%) 
Apprenticeship  52 (18.8%) 
University degree  107 
(38.6%) 
Social support   
Lives with partner  280 
(90.6%) 
Lives alone  29 (9.4%) 
Weight (kg) at the first GDM visit 78.3 
(14.8)  
Weight (kg) at the last GDM visit 80.6 
(14.8)  
Weight gain (kg) between the first and last GDM visit 2.4 (3.5)  
BMI at the first GDM visit 29.2 (5.3)  
Obstetric variables   
Gestational age (weeks) at first GDM visit 28.9 (3.3)  
Gestational age (weeks) at last GDM visit 36.2 (1.9)  
Mental health variables   
Depression total score at first GDM visit 7.5 (5.5)  
Depression cut-off ≥11 at first GDM visit  76 (26.0%) 
Well-being total score at first GDM visit 60.3 
(20.5)  
Well-being total score at last GDM visit 67.4 
(17.9)  
BMI: body mass index, GDM: gestational diabetes mellitus, Kg: kilograms. 
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association between the well-being total score and the depression cut-off 
≥11 (i.e., elevated depression score) at the first GDM visit (β = − 21.77; 
r = − 0.47; p < 0.0001, see Table 2) were found. These associations 
remained significant after adjustments for confounders (β = − 1.95; p <
0.0001 and β = − 20.93; p < 0.0001; see Table 2). 
3.3. Associations between mental health and weight variables 
We found no significant associations between the depression total 
score and the cut-off ≥11 (i.e., elevated depression score) at the first 
GDM visit and weight at the same moment (β = 0.05; p = 0.76 and β =
0.78; p = 0.69), even after adjustments for confounders (β = 0.04 and β 
= 1.53; both p ≥ 0.49; see Table 3a). There were no significant associ-
ations between the depression total score at the first GDM visit and 
subsequent weight gain, regardless of adjustments (β = 0.06; p = 0.19 in 
Model 1 and β = − 0.01; p = 0.82 in Model 2). On the other hand, 
positive and significant associations between the depression cut-off ≥11 
at the first GDM visit and subsequent weight gain during pregnancy 
were found (β = 1.25; p = 0.02). After controlling for confounders, this 
association did not remain significant (β = 0.24; p = 0.69; see Table 3b). 
The associations between the well-being total score at first GDM visit 
with concurrent weight and subsequent weight gain (β = − 0.06; p =
0.19 and β = 0.007; p = 0.53) were not significant. After adjustments, 
there was a trend towards an inverse association between the well-being 
total score and weight at the first GDM visit, but not with weight gain (β 
= − 0.09; p = 0.07 and β = 0.01; p = 0.38; see Tables 3a and 3b). 
4. Discussion 
In this prospective clinical cohort study of women with GDM, well- 
being after GDM diagnosis (first GDM visit) was inversely associated 
with the depression total score and the depression cut-off ≥11 (i.e., 
elevated depression score). The elevated depression score was positively 
associated with subsequent weight gain during pregnancy, whereas, 
neither well-being nor depression total scores in general were associated 
with weight or weight gain. 
In this cohort, well-being increased by 11.8% between the first GDM 
visit after diagnosis and the last GDM visit before delivery (during a 
mean of seven weeks); a context of significant changes for pregnant 
women with GDM. A study conducted in a general pregnant population 
demonstrated that women had a mean WHO-5 third trimester total score 
of 58.4 ± 22 [54], which is lower than the total score in our population. 
This suggests that women in the current cohort had the capacity to 
recover from the initial diagnosis of GDM, and that the diagnosis itself 
did not have a major impact on their well-being. Another study inves-
tigated the change in well-being in a primary care setting of psychiatric 
patients [48] and showed that a change of 11 points on the WHO-5 scale 
demonstrated a clinically significant change in well-being. The increase 
of 7.1 points between the first and last GDM visit in our patients, could 
be due to the help offered by various professionals, who counsel, 
accompany and help them with regards to their understanding of the 
GDM diagnosis, their lifestyle and glucose management. This might 
bring some reassurance to these women, as they might feel cared for. 
This is corroborated by a study, which showed improvement in mood, 
quality of life, and decreased rates of postpartum depression in women 
with GDM who received dietary advice, blood glucose monitoring, and 
insulin therapy, as needed, from 24 to 34 weeks of gestation, compared 
to a routine care group [55]. In our patients, this improvement in mental 
health already occurred earlier, i.e., during pregnancy. It would there-
fore be interesting to investigate further possible changes in well-being 
in the postpartum period. 
It seems compelling that the well-being total score was inversely 
associated with the depression total score and the depression cut-off ≥11 
as previous studies have demonstrated that well-being was lower in non- 
pregnant populations suffering from major depression compared to in-
dividuals with no depression [24]. We also showed that the well-being 
total score only explained around 25% of our two depression variables 
(both r around 0.5). This means that depression and well-being items 
also give distinct information and, thus, are both important to investi-
gate in women with GDM. This finding is corroborated by another study 
concluding that, while mild and moderate levels of depression were 
negatively associated with well-being, the WHO-5 demonstrates ineffi-
cacy in detecting severe and extreme forms of depression [25]. 
Despite the fact that depression has been shown to be associated with 
metabolic health, especially with weight, in the general pregnant pop-
ulation [27–29,56], we did not find any associations between the 
depression variables and weight in our cohort. The prospective 
Table 2 
Association between mental health variables in women with GDM.   




confidence interval)  
Well-being total score at the first GDM visit 
Depression total score at the 
first GDM visit 
− 2.08 (− 2.45 to − 1.71) 
** 
− 1.95 (− 2.37 to − 1.53) 
** 
Depression cut-off ≥ 11 at 
the first GDM visit 
− 21.77 (− 26.50 to 
− 17.04)** 
− 20.93 (− 26.20 to 
− 15.62)** 
* p < 0.05, ** p < 0.01. 
GDM: gestational diabetes mellitus. 
Model 1 was an unadjusted linear regression model. Model 2 was a linear 
regression model with adjustments for: Maternal age, gestational age, educa-
tional level, social support and BMI at the first GDM visit. 
Table 3a 
Association between mental health variables and weight in women with GDM.   




confidence interval)  
Weight (kg) at the first GDM visit 
Depression total score at the 
first GDM visit 
0.05 (− 0.26 to 0.36) 0.04 (− 0.31 to 0.39) 
Depression cut-off of ≥ 11 at 
the first GDM visit 
0.78 (− 3.01 to 4.57) 1.53 (− 2.79 to 5.86) 
Well-being total score at the 
first GDM visit 
− 0.06 (− 0.14 to 0.03) − 0.09 (− 0.18 to 0.01) 
* p < 0.05, ** p < 0.01. 
GDM: gestational diabetes mellitus, Kg: kilograms. 
Model 1 was an unadjusted linear regression model. Model 2 was a linear 
regression model with adjustments for: Maternal age, gestational age, educa-
tional level and social support at the first GDM visit. 
Table 3b 
Associations between mental health variables and weight gain in women with 
GDM.   




confidence interval)  
Weight gain (kg) between the first and last GDM visit 
Depression total score at the 
first GDM visit 
0.06 (− 0.03 to 0.14) − 0.01 (− 0.10 to 0.08) 
Depression cut-off of ≥ 11 at 
the first GDM visit 
1.25 (0.20 to 2.29)* 0.24 (− 0.91 to 1.38) 
Well-being total score at the 
first GDM visit 
0.01 (− 0.02 to 0.03) 0.01 (− 0.01 to 0.04) 
* p < 0.05, ** p < 0.01. 
GDM: gestational diabetes mellitus, Kg: kilograms. 
Model 1 was an unadjusted linear regression model. Model 2 was a linear 
regression model with adjustments for: Maternal age, gestational age, educa-
tional level, social support and BMI at the first GDM visit. 
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association we found between the depression cut-off ≥11 at first GDM 
visit and subsequent weight gain is interesting and in line with previous 
studies. These previous studies show that depression measured by the 
EPDS or by the DASS (Depression Anxiety Stress Scales), using cut-off 
scores, was associated with excessive weight gain in pregnancy and in 
the general population [28,29]. However, the association we found 
between the depression cut-off ≥11 and weight gain did not remain 
significant when we controlled for confounding factors, such as 
maternal age, gestational age, educational level, social support and BMI 
at the first GDM visit. Furthermore, we did not find an association be-
tween the depression total score and subsequent weight gain, which 
contradicts previous research. In previous studies, in obese non- 
pregnant individuals, depression was associated with over-eating, 
which led to weight gain [57]. Our findings may hint to a non-linear 
association between mental health and weight gain in pregnancy that 
is only present above a certain cut-off when elevated depression scores 
arise. In women with GDM, there might even be a synergistic effect of 
depression and weight gain that amplifies adverse outcomes in the 
mother and the infant. Nevertheless, the 7 weeks’ time interval in which 
we measured the association between depression and weight (gain) 
might also have been too short to show sufficient significant changes 
regarding this relationship. Thus, it would be helpful to investigate this 
topic in larger studies and over a longer time period. 
Finally, we found no association between the well-being total score 
and weight or weight gain. Our results are in conflict with other studies, 
in which well-being was inversely associated with weight in non- 
pregnant individuals [58] and with weight retention in the post-
partum period [31]. It seems that other clinical factors might have 
played a role and thus, future research should investigate the relation-
ship between well-being and weight (gain), especially since our results 
showed a trend towards an inverse association between the well-being 
total score and weight at the first GDM visit. 
4.1. Clinical implications 
Our results showing that well-being augmented by 11.8% between 
the first and last GDM visit is of clinical relevance. Indeed, this may 
suggest that a good and comprehensive clinical follow-up may coun-
teract the negative emotional impact of a GDM diagnosis [4], although 
this would need to be confirmed by an RCT. Our findings demonstrating 
that well-being was inversely correlated to depression and explained 
around 25% of its variance imply that other factors might impact both 
mental health variables and that it is more informative to measure them 
both in women with GDM. 
Of further clinical relevance is the association of the depression cut- 
off ≥11 (i.e., elevated depression score) with subsequent weight gain 
during GDM pregnancy. This highlights the importance of screening 
women’s mental health during pregnancy, as recommended by the 
National Institute for Health and Clinical Excellence [59] and the ADA 
[60]. As weight gain in pregnancy and in women with GDM may have a 
deleterious impact on the mother and the child [30,51,61–64], actions 
may be taken to lower their depressive symptoms as a means to 
restricting weight gain during pregnancy. Given our results and the re-
sults of a recent review together [19], women with GDM may not only 
benefit from being screened but also treated for mental health symptoms 
early after their GDM diagnosis. Furthermore, this study suggests that 
future studies should investigate the effect of mental health variables on 
other metabolic parameters in women with GDM during pregnancy and 
in the postpartum, as weight gain may not be the only variable that is 
influenced by elevated depression scores. 
4.2. Strengths and limitations 
This study has many strengths, including the prospective design 
investigating a “real-life” clinical cohort of consecutive women, the use 
of validated self-report questionnaires, and the inclusion of influential 
confounding variables. This study also included women speaking other 
languages then French and English, thus increasing generalizability and 
reflecting the GDM population in Switzerland. Nevertheless, some lim-
itations need to be addressed. First, a longer time period might have 
yielded more pronounced results regarding the relationship between 
mental health and weight gain, as weight gain was only 2.4 kg during 
the short time-frame studied in our cohort. It would also be interesting to 
investigate these relationships up to the postpartum period and there-
fore to evaluate the potential effect of mental health on weight retention 
after delivery. Second, additional confounders that could not be 
accounted for might have affected our results, such as diet and physical 
activity behaviours, as well as ethnicity and potential psychotropic 
medication use [19]. Third, these women also met different pro-
fessionals during their pregnancy, advising them about their diet and 
lifestyle behavior, which might have influenced their weight gain. 
Fourth, as this paper has an explorative nature, we did not account for 
previous mental health diagnosis, as is the case for similar papers in this 
domain [4]. Finally, there may be a high attrition rate, as this study took 
place in a clinical setting. 
5. Conclusion 
This prospective clinical cohort study indicated that in women with 
GDM, well-being increased by 11.8% after GDM diagnosis until the end 
of pregnancy. The well-being total score was inversely related to the 
depression total score and cut-off of ≥11 (i.e., elevated depression score) 
and explained around 25% of their variability. This shows that positive 
emotional health should be fostered and integrated in the care of women 
with GDM. Furthermore, the depression cut-off ≥11 was associated with 
subsequent weight gain, showing the importance of screening mental 
health in women with GDM. 
Funding 
This work was supported by the Swiss National Science Foundation 
[SNF 32003B_176119] and by an unrestricted educational grant from 
NovoNordisk. 
Competing interest statement 
The authors have no competing interests to report. 
Acknowledgements 
We would like to give a special thanks to our colleagues that 
collected and entered data for this study: Isabelle Cohen, Justine Gross, 
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